Paragon Health Institute Icon White

Dr. Joel Zinberg Quoted in The Dispatch

Dispatch Zinberg
Director at Public Health and American Well-Being Initiative
Joel M. Zinberg, M.D., J.D. is the Director of the Public Health and American Well-Being Initiative at Paragon Health Institute, and a senior fellow with the Competitive Enterprise Institute. A native New Yorker, he recently completed two years as General Counsel and Senior Economist at the Council of Economic Advisers in the Executive Office of the President.

On December 12, 2023, Paragon’s Dr. Joel Zinberg was quoted in The Dispatch article “Biden Targets the Pharmaceutical Industry.”

From the article:

Before that act, anytime there was an invention made with government-funded research, the government owned the patent,” said Joel Zinberg, a director at the Paragon Health Institute and former senior economist at the White House Council of Economic Advisers during the Trump administration. “They would only grant non-exclusive licenses to developers. So you had a situation where few companies were going to invest the money and time necessary to transform the discovery into a practical product unless they could own it and exclude others from using it.” This is particularly true for pharmaceuticals, which can take millions (sometimes hundreds of millions) of dollars to develop and years to progress through clinical trials before they can be sold.

The full article can be found in The Dispatch.

Related Content


Sign up now for your health policy updates.

This field is for validation purposes and should be left unchanged.